ArticleBMJ open2026

PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial.

Zhongxiu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.